InteRNA has a worldwide exclusive license and full commercial rights to patent applications covering:
- a vast collection of novel miRNA sequences that serves as product engine;
- technologies for identification and detection of miRNAs.
These patent applications cover different classes of claims ranging from product claims to method claims.
In addition, InteRNA owns several patent applications covering both method claims and use claims, protecting the use of specific miRNA mimics or antagomirs for therapeutic and diagnostic applications.
InteRNA has exclusive worldwide IP rights on the next-gen LNP formulation icw miRNAs for all disease indications.